Filing Details

Accession Number:
0001225208-15-013736
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-12 09:26:48
Reporting Period:
2015-06-11
Filing Date:
2015-06-12
Accepted Time:
2015-06-12 09:26:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553231 J Laurie Olson Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-11 26,000 $25.87 96,113 No 4 M Direct
Common Stock Disposition 2015-06-11 100 $34.35 96,013 No 4 S Direct
Common Stock Disposition 2015-06-11 500 $34.36 95,513 No 4 S Direct
Common Stock Disposition 2015-06-11 900 $34.37 94,613 No 4 S Direct
Common Stock Disposition 2015-06-11 5,500 $34.39 89,113 No 4 S Direct
Common Stock Disposition 2015-06-11 6,900 $34.38 82,213 No 4 S Direct
Common Stock Disposition 2015-06-11 12,100 $34.40 70,113 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-06-11 26,000 $0.00 26,000 $25.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-02-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,918 Indirect By Rule 16b-3 Plan
Footnotes
  1. These options are fully exercisable.